1. August uplisting now probable.

2. With two possible Covid-19 approvals by by end of August most likely but by years end either way most believe.

3. With a September BTD for cancer to be filed and a up to 60 day review for the data before approval or not approved at years end.

4. HIV duel therapy by end of year possible.

With these 4 catalyst seeming likely to happen for the optimists on this board that believe in Leronlimab and see their glass over half full.

Let’s play the guessing game... what is your prediction for end of the year stock price “ if “ all these catalysts do come true?

My guess is $105/share...

What is your guess???

Live a little and venture a guess...